Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Syndax Pharmaceuticals Inc | Director | Stock Options (Right to buy) | 35K | $780K | $22.28 | May 15, 2024 | Direct |
GERON CORP | EVP, Chief Medical Officer | Employee Stock Option (right to buy) | 750K | Feb 16, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SNDX | Syndax Pharmaceuticals Inc | May 15, 2024 | 1 | $0 | 4 | May 16, 2024 | Director |
SNDX | Syndax Pharmaceuticals Inc | May 15, 2024 | 0 | $0 | 3 | May 16, 2024 | Director |
GERN | GERON CORP | Feb 16, 2022 | 1 | $0 | 4 | Feb 18, 2022 | EVP, Chief Medical Officer |